Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2897PDF: 1042HTML: 5631 -
IMMUNOLOGY OF TUBERCULOSIS
5602PDF: 2056HTML: 7352Untitled: 209 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3466PDF: 2305HTML: 23466Untitled: 219Untitled: 233Untitled: 245 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3583PDF: 913HTML: 1671figure 1: 180Untitled: 206 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3568PDF: 1327HTML: 2046Fig.1: 227Fig. 2: 223 -
Guest Editor: Raffaella Origa IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION: TIME TO CHANGE THE PARADIGM. IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION
2003PDF: 1242HTML: 315 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1430PDF: 832HTML: 1025 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1712PDF: 568HTML: 243 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
1740PDF: 500HTML: 4033 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
1016PDF: 1243HTML: 120 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1153PDF: 1104HTML: 492 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2411PDF: 1208HTML: 281 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1324PDF: 1066HTML: 404
1 - 28 of 28 items







